Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indofarma Tbk. (INAF) vs Sawit Sumbermas Sarana Tbk (SSMS) Price & Performance

Indofarma Tbk.Trade
Sawit Sumbermas Sarana TbkTrade

Price performance (Past 24H)

Key statistics

Indofarma Tbk. vs Sawit Sumbermas Sarana Tbk — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Sawit Sumbermas Sarana Tbk trades at Rp1,195 (market cap 11.38T, 9.52M 24h volume). The key difference: Sawit Sumbermas Sarana Tbk is far larger — about 29.1× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.

INAFSSMS
Market Cap
390.51B11.38T
Volume
9.52M
Lot
95.2K
Turnover
11.42B
Average Price
1,199.09
Value
11.42B
Indicative Equilibrium Price
1,195
Indicative Equilibrium Volume
300

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INAF
View details
SSMS
View details

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF

About Sawit Sumbermas Sarana Tbk

PT Sawit Sumbermas Sarana Tbk (the Company) was established in Jakarta based on the Notarial Deed No. 51 of Enimarya Agoes Suwarko, S.H., dated November 22, 1995.

Read more on SSMS